The Second Australian National Blood Pressure ( ANBP2 ) study randomized 6,083 hypertensive patients aged 65-84 years to angiotensin-converting enzyme inhibitor ( ACEI ) or thiazide diuretic-based therapy and followed them for a median of 4.1 years .